EUR 0.0
(7.69%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.55 Million EUR | -67.4% |
2022 | 29.32 Million EUR | 48.31% |
2021 | 19.77 Million EUR | -20.39% |
2020 | 24.83 Million EUR | 10.91% |
2019 | 22.39 Million EUR | -13.05% |
2018 | 25.75 Million EUR | 2.3% |
2017 | 25.17 Million EUR | -34.76% |
2016 | 38.58 Million EUR | -23.42% |
2015 | 50.38 Million EUR | 108.18% |
2014 | 24.2 Million EUR | 88.92% |
2013 | 12.81 Million EUR | -11.15% |
2012 | 14.41 Million EUR | -4.22% |
2011 | 15.05 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 9.39 Million EUR | -1.71% |
2024 Q2 | 9.39 Million EUR | 0.0% |
2023 Q4 | 9.55 Million EUR | 0.0% |
2023 Q3 | 9.55 Million EUR | -8.02% |
2023 FY | 9.55 Million EUR | -67.4% |
2023 Q1 | 10.39 Million EUR | -64.56% |
2023 Q2 | 10.39 Million EUR | 0.0% |
2022 Q4 | 29.32 Million EUR | 0.0% |
2022 FY | 29.32 Million EUR | 48.31% |
2022 Q2 | 11.73 Million EUR | 0.0% |
2022 Q3 | 29.32 Million EUR | 149.95% |
2021 Q2 | 14.32 Million EUR | 0.0% |
2021 Q4 | 19.77 Million EUR | 0.0% |
2021 FY | 19.77 Million EUR | -20.39% |
2020 FY | 24.83 Million EUR | 10.91% |
2020 Q4 | 24.83 Million EUR | 0.0% |
2020 Q2 | 22.64 Million EUR | 0.0% |
2019 Q4 | 22.39 Million EUR | 0.0% |
2019 Q2 | 27.93 Million EUR | 0.0% |
2019 FY | 22.39 Million EUR | -13.05% |
2018 Q2 | 24.43 Million EUR | 0.0% |
2018 FY | 25.75 Million EUR | 2.3% |
2018 Q4 | 25.75 Million EUR | 0.0% |
2017 Q4 | 25.17 Million EUR | 0.0% |
2017 FY | 25.17 Million EUR | -34.76% |
2017 Q2 | 29.84 Million EUR | 0.0% |
2016 Q2 | 43.38 Million EUR | 0.0% |
2016 Q4 | 38.58 Million EUR | 0.0% |
2016 FY | 38.58 Million EUR | -23.42% |
2015 Q2 | 51.3 Million EUR | 0.0% |
2015 Q4 | 50.38 Million EUR | 0.0% |
2015 FY | 50.38 Million EUR | 108.18% |
2014 Q4 | 24.2 Million EUR | 86.59% |
2014 Q3 | 12.97 Million EUR | 0.0% |
2014 FY | 24.2 Million EUR | 88.92% |
2013 FY | 12.81 Million EUR | -11.15% |
2013 Q4 | 12.81 Million EUR | 0.0% |
2012 FY | 14.41 Million EUR | -4.22% |
2011 FY | 15.05 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Nicox S.A. | 52.98 Million EUR | 81.957% |
European Medical Solutions | 43.75 Million EUR | 78.155% |
FERMENTALG | 50.24 Million EUR | 80.975% |
argenx SE | 4.11 Billion EUR | 99.768% |
Celyad Oncology SA | 16.28 Million EUR | 41.291% |
Hyloris Pharmaceuticals SA | 47.68 Million EUR | 79.952% |
Onward Medical N.V. | 43.62 Million EUR | 78.09% |
Oxurion NV | 6.55 Million EUR | -45.939% |
PHAXIAM Therapeutics S.A. | 51.3 Million EUR | 81.369% |
Financière de Tubize SA | 1.92 Billion EUR | 99.502% |
UCB SA | 15.53 Billion EUR | 99.938% |